These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 11784524)

  • 1. [Changes in the clinical profile of patients treated with oral anticoagulants in the 1990's].
    Vázquez Ruiz De Castroviejo E; Martín Barranco MJ; Martín Rubio A; Fajardo Pineda A; Lozano Cabezas C; Guzmán Herrera M; Tarabini Castellani A; Pagola Vilardebó C; Martínez Galiano E; Alcalá Muñoz A
    Rev Esp Cardiol; 2002 Jan; 55(1):55-60. PubMed ID: 11784524
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Perioperative bleeding and thromboembolic risk during non-cardiac surgery in patients with mechanical prosthetic heart valves: an institutional review.
    Carrel TP; Klingenmann W; Mohacsi PJ; Berdat P; Althaus U
    J Heart Valve Dis; 1999 Jul; 8(4):392-8. PubMed ID: 10461238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and efficacy of enoxaparin compared with unfractionated heparin and oral anticoagulants for prevention of thromboembolic complications in cardioversion of nonvalvular atrial fibrillation: the Anticoagulation in Cardioversion using Enoxaparin (ACE) trial.
    Stellbrink C; Nixdorff U; Hofmann T; Lehmacher W; Daniel WG; Hanrath P; Geller C; Mügge A; Sehnert W; Schmidt-Lucke C; Schmidt-Lucke JA;
    Circulation; 2004 Mar; 109(8):997-1003. PubMed ID: 14967716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Advantages of a cardiologic ambulatory care facility specifically organized for patients undergoing treatment with oral anticoagulant drugs].
    Pengo V; Peruzzi P; Marzari A; Zanon F; Banzato A; Schivazappa L
    G Ital Cardiol; 1989 Dec; 19(12):1125-8. PubMed ID: 2561357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The frequency of risk factors of thromboembolic and hemorrhagic complications in patients treated with oral anticoagulants after heart valve replacement].
    Wołkanin-Bartnik J; Zieliński T; Pogorzelska H; Browarek A; Leszek P; Korewicki J
    Pol Merkur Lekarski; 2005 May; 18(107):503-10. PubMed ID: 16161943
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Oral anticoagulant therapy--renaissance of an old therapy?].
    Lechner K; Korninger C; Kyrle P; Geissler K; Niessner H; Pabinger I; Panzer S; Gössinger H; Bettelheim P; Hinterberger W
    Wien Klin Wochenschr; 1987 Apr; 99(7):203-10. PubMed ID: 3590801
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prevention of thromboembolic complications with adapted low-dose of antivitamins K after total hip prosthesis].
    Hernigou P; Février MJ; Kergrohen F
    Rev Chir Orthop Reparatrice Appar Mot; 1993; 79(7):577-85. PubMed ID: 8085039
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Artificial circulatory support with textured interior surfaces. A counterintuitive approach to minimizing thromboembolism.
    Rose EA; Levin HR; Oz MC; Frazier OH; Macmanus Q; Burton NA; Lefrak EA
    Circulation; 1994 Nov; 90(5 Pt 2):II87-91. PubMed ID: 7955291
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Population-based evaluation of the management of antithrombotic therapy for atrial fibrillation.
    Anderson DR; Gardner MJ; Putnam W; Jassal D; Brownell B; Flowerdew G; Nagpal S; Thompson K; Cox JL
    Can J Cardiol; 2005 Mar; 21(3):257-66. PubMed ID: 15776115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Occurrence of thromboembolic complications in patients with dilated cardiomyopathy. Retrospective-prospective study].
    Polić S; Biocić M; Lukin A; Rumboldt Z; Bagatin J; Pivac N; Rakić D; Naranca M
    Lijec Vjesn; 1997; 119(5-6):142-6. PubMed ID: 9379820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toward effective long-term prevention of thromboembolism: novel oral anticoagulant delivery systems.
    Homar M; Cegnar M; Kotnik M; Peternel L
    Semin Thromb Hemost; 2010 Feb; 36(1):113-22. PubMed ID: 20391302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preventing thromboembolism in patients with prosthetic heart valves.
    Turpie AG
    Cardiol Clin; 1994 Aug; 12(3):487-93. PubMed ID: 7805081
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of a moderate with moderate-high intensity oral anticoagulant treatment in patients with mechanical heart valve prostheses.
    Pengo V; Barbero F; Banzato A; Garelli E; Noventa F; Biasiolo A; Zasso A; Dalla Volta S
    Thromb Haemost; 1997 May; 77(5):839-44. PubMed ID: 9184389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antithrombotic therapy practices in US hospitals in an era of practice guidelines.
    Tapson VF; Hyers TM; Waldo AL; Ballard DJ; Becker RC; Caprini JA; Khetan R; Wittkowsky AK; Colgan KJ; Shillington AC;
    Arch Intern Med; 2005 Jul; 165(13):1458-64. PubMed ID: 16009860
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Heart failure and arrhythmia: modalities and indications of prevention of thromboembolism].
    Prati PL; Piazza V
    Cardiologia; 1994 Dec; 39(12 Suppl 1):353-6. PubMed ID: 7634296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Anticoagulation therapy in cardiac patients with mechanical valve prostheses].
    Milosević U; Anojcić S
    Srp Arh Celok Lek; 1990; 118(11-12):481-9. PubMed ID: 2133607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Laparoscopic renal-adrenal surgery in patients on oral anticoagulant therapy.
    Varkarakis IM; Rais-Bahrami S; Allaf ME; Lima GC; Permpongkosol S; Rao P; Jarrett TW; Kavoussi LR
    J Urol; 2005 Sep; 174(3):1020-3; discussion 1023. PubMed ID: 16094036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Necessity of permanent anticoagulant therapy for isolated mitral valve replacement with bioprosthetic heart valve to prevent the postoperative thromboembolic complications].
    Yao H; Miyamoto T; Yamashita K; Mukai M; Wada T; Yamamura M; Nakagawa T; Ryomoto M
    Kyobu Geka; 2000 Apr; 53(4):337-40. PubMed ID: 10770064
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Anticoagulant treatment and cardiac insufficiency].
    Bounhoure JP; Galinier M; Pathak A
    Arch Mal Coeur Vaiss; 2000 Feb; 93 Spec No 2():29-32. PubMed ID: 10830086
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risks of oral anticoagulant therapy with increasing age.
    Torn M; Bollen WL; van der Meer FJ; van der Wall EE; Rosendaal FR
    Arch Intern Med; 2005 Jul; 165(13):1527-32. PubMed ID: 16009869
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.